{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:32:15Z","timestamp":1790937135094,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Molecular Biology"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.jmb.2006.09.084","type":"journal-article","created":{"date-parts":[[2006,10,4]],"date-time":"2006-10-04T07:50:52Z","timestamp":1159948252000},"page":"196-210","source":"Crossref","is-referenced-by-count":107,"title":["Fine and Domain-level Epitope Mapping of Botulinum Neurotoxin Type A Neutralizing Antibodies by Yeast Surface Display"],"prefix":"10.1016","volume":"365","author":[{"given":"R.","family":"Levy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.M.","family":"Forsyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.L.","family":"LaPorte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.N.","family":"Geren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.D.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmb.2006.09.084_bib1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/MMBR.46.1.86-94.1982","article-title":"Bacterial toxins: a table of lethal amounts","volume":"46","author":"Gill","year":"1982","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.jmb.2006.09.084_bib2","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/2338","article-title":"Crystal structure of botulinum neurotoxin type A and implications for toxicity","volume":"5","author":"Lacy","year":"1998","journal-title":"Nature Struct. Biol."},{"key":"10.1016\/j.jmb.2006.09.084_bib3","first-page":"16","article-title":"Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction","volume":"212","author":"Simpson","year":"1980","journal-title":"J. Pharmacol. Expt. Ther."},{"key":"10.1016\/j.jmb.2006.09.084_bib4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1017\/S0033583500003292","article-title":"Structure and function of tetanus and botulinum neurotoxins","volume":"28","author":"Montecucco","year":"1995","journal-title":"Quart. Rev. Biophys."},{"key":"10.1016\/j.jmb.2006.09.084_bib5","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1123654","article-title":"SV2 is the protein receptor for botulinum neurotoxin A","volume":"312","author":"Dong","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.jmb.2006.09.084_bib6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/307457a0","article-title":"Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization","volume":"307","author":"Dolly","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2006.09.084_bib7","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.febslet.2006.02.074","article-title":"The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves","volume":"580","author":"Mahrhold","year":"2006","journal-title":"FEBS Letters"},{"key":"10.1016\/j.jmb.2006.09.084_bib8","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/359832a0","article-title":"Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin","volume":"359","author":"Schiavo","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2006.09.084_bib9","doi-asserted-by":"crossref","first-page":"23784","DOI":"10.1016\/S0021-9258(20)80452-9","article-title":"Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E","volume":"268","author":"Schiavo","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2006.09.084_bib10","series-title":"Handbook for Epidemiologists, Clinicians, and Laboratory Workers, Atlanta, GA","article-title":"Botulism in the United States, 1899\u20131998","author":"Centers for Disease Control.","year":"1998"},{"key":"10.1016\/j.jmb.2006.09.084_bib11","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.285.8.1059","article-title":"Botulinum toxin as a biological weapon: medical and public health management","volume":"285","author":"Arnon","year":"2001","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.jmb.2006.09.084_bib12","unstructured":"United Nations Security Council. (1995). Tenth report of the executive committee of the Special Commision established by the Secretary-General pursuant to paragraph 9 (b) (I) of Security Council resolution 687 (1991), and paragraph 3 of resolution 699 (1991) on the activities of the Special Commision Council, U.N.S.S\/1995\/1038."},{"key":"10.1016\/j.jmb.2006.09.084_bib13","unstructured":"Bozheyeva, G., Kunakbayev, Y. & Yeleukenov, D. (1999). Former Soviet biological weapons facilities in Kazakhstan: past, present, and future. June 1999: 1\u201320. Occasional paper no.1, Center for Nonproliferation Studies, Monterey Institute of International Studies, Monterey."},{"key":"10.1016\/j.jmb.2006.09.084_bib14","series-title":"Botulinum and Tetanus Neurotoxins: Neurotransmission and Biomedical Aspects","first-page":"473","author":"Franz","year":"1993"},{"key":"10.1016\/j.jmb.2006.09.084_bib15","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0002-9343(80)90469-6","article-title":"Hypersensitivity reactions associated with botulinal antitoxin","volume":"69","author":"Black","year":"1980","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jmb.2006.09.084_bib16","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/S0264-410X(01)00482-0","article-title":"Genetic and immunological comparison of anti-botulinum type A antibodies from immune and non-immune human phage libraries","volume":"20","author":"Amersdorfer","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.jmb.2006.09.084_bib17","doi-asserted-by":"crossref","first-page":"11346","DOI":"10.1073\/pnas.172229899","article-title":"Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody","volume":"99","author":"Nowakowski","year":"2002","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jmb.2006.09.084_bib18","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/78005","article-title":"Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B","volume":"7","author":"Swaminathan","year":"2000","journal-title":"Nature Struct. Biol."},{"key":"10.1016\/j.jmb.2006.09.084_bib19","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1107\/S0907444901013531","article-title":"Crystallographic evidence for doxorubicin binding to the receptor-binding site in Clostridium botulinum neurotoxin B","volume":"57","author":"Eswaramoorthy","year":"2001","journal-title":"Acta Crystallog. sect. D"},{"key":"10.1016\/j.jmb.2006.09.084_bib20","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nbt0697-553","article-title":"Yeast surface display for screening combinatorial polypeptide libraries","volume":"15","author":"Boder","year":"1997","journal-title":"Naturer Biotechnol."},{"key":"10.1016\/j.jmb.2006.09.084_bib21","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jmb.2004.07.053","article-title":"Fine epitope mapping of anti-epidermal growth factor receptor antibodies through random mutagenesis and yeast surface display","volume":"342","author":"Chao","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2006.09.084_bib22","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jmb.2005.06.003","article-title":"Molecular evolution of antibody affinity for sensitive detection of botulinum neurotoxin type A","volume":"351","author":"Razai","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2006.09.084_bib23","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1128\/IAI.69.10.6511-6514.2001","article-title":"Epitope mapping of neutralizing botulinum neurotoxin A antibodies by phage display","volume":"69","author":"Mullaney","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jmb.2006.09.084_bib24","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1128\/IAI.65.9.3743-3752.1997","article-title":"Molecular characterization of murine humoral immune response to botulinum neurotoxin type A binding domain as assessed using phage antibody libraries","volume":"65","author":"Amersdorfer","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jmb.2006.09.084_bib25","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1128\/IAI.73.9.5450-5457.2005","article-title":"Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization","volume":"73","author":"Smith","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jmb.2006.09.084_bib26","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1006\/abio.1995.1050","article-title":"Direct random mutagenesis of gene-sized DNA fragments using polymerase chain reaction","volume":"224","author":"Fromant","year":"1995","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jmb.2006.09.084_bib27","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1126\/science.2471267","article-title":"High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis","volume":"244","author":"Cunningham","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.jmb.2006.09.084_bib28","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0076-6879(91)02020-A","article-title":"Systematic mutational analyses of protein-protein interfaces","volume":"202","author":"Wells","year":"1991","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.jmb.2006.09.084_bib29","first-page":"6434","article-title":"Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity","volume":"60","author":"Nielsen","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.jmb.2006.09.084_bib30","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1006\/jmbi.1999.2945","article-title":"Sequence homology and structural analysis of the Clostridial neurotxins","volume":"291","author":"Lacy","year":"1999","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2006.09.084_bib31","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1046\/j.1365-2958.2003.03872.x","article-title":"The HCC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction","volume":"51","author":"Rummel","year":"2004","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.jmb.2006.09.084_bib32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.febslet.2004.06.094","article-title":"Interaction between the two subdomains of the C-terminal part of the botulinum neurotoxin A is essential for the generation of protective antibodies","volume":"572","author":"Tavallaie","year":"2004","journal-title":"FEBS Letters"},{"key":"10.1016\/j.jmb.2006.09.084_bib33","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1046\/j.1471-4159.2000.0741941.x","article-title":"Tetanus toxin fragment C binds to a protein present in neuronal cell lines and motoneurons","volume":"74","author":"Herreros","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jmb.2006.09.084_bib34","first-page":"149","article-title":"SPOT synthesis. Epitope analysis with arrays of synthetic peptides prepared on cellulose membranes","volume":"66","author":"Frank","year":"1996","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jmb.2006.09.084_bib35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0022-1759(01)00461-6","article-title":"Epitope mapping and affinity purification of monospecific antibodies by Escherichia coli cell surface display of gene-derived random peptide libraries","volume":"257","author":"Christmann","year":"2001","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jmb.2006.09.084_bib36","first-page":"241","article-title":"Random fragment libraries using yeast expression plasmid","volume":"66","author":"Benichou","year":"1996","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jmb.2006.09.084_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1389450043490668","article-title":"Epitope identification and discovery using phage display libraries: applications in vaccine development and diagnostics","volume":"5","author":"Wang","year":"2004","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.jmb.2006.09.084_bib38","doi-asserted-by":"crossref","first-page":"7013","DOI":"10.1073\/pnas.83.18.7013","article-title":"Efficient mapping of protein antigenic determinants","volume":"83","author":"Mehra","year":"1986","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jmb.2006.09.084_bib39","doi-asserted-by":"crossref","first-page":"8950","DOI":"10.1073\/pnas.160252097","article-title":"Rapid mapping of protein functional epitopes by combinatorial alanine scanning","volume":"97","author":"Weiss","year":"2000","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jmb.2006.09.084_bib40","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0022-2836(02)00264-4","article-title":"Comprehensive functional maps of the antigen-binding site of an anti-ErbB2 antibody obtained with shotgun scanning mutagenesis","volume":"320","author":"Vajdos","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2006.09.084_bib41","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nm1240","article-title":"Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus","volume":"11","author":"Oliphant","year":"2005","journal-title":"Nature Med."},{"key":"10.1016\/j.jmb.2006.09.084_bib42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jim.2004.02.011","article-title":"Novel application of an in vitro technique to the detection and quantification of botulinum neurotoxin antibodies","volume":"288","author":"Hall","year":"2004","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jmb.2006.09.084_bib43","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1182\/blood.V85.4.917.bloodjournal854917","article-title":"Pharmacokinetic study of anti-interleukin-6 (IL-6) therapy with monoclonal antibodies: enhancement of IL-6 clearance by cocktails of anti-IL-6 antibodies","volume":"85","author":"Montero-Julian","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2006.09.084_bib44","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1128\/IAI.63.7.2738-2742.1995","article-title":"Protective vaccination with a recombinant fragment of Clostridium botulinum neurotoxin serotype A expressed from a synthetic gene in Escherichia coli","volume":"63","author":"Clayton","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jmb.2006.09.084_bib45","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1006\/prep.2000.1256","article-title":"Production and purification of the heavy chain fragment C of botulinum neurotoxin, serotype A, expressed in the methylotrophic yeast Pichia pastoris","volume":"19","author":"Potter","year":"2000","journal-title":"Protein Expr. Purif."},{"issue":"Suppl. 8","key":"10.1016\/j.jmb.2006.09.084_bib46","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1002\/mds.20009","article-title":"Roads from vaccines to therapies","volume":"19","author":"Smith","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jmb.2006.09.084_bib47","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1023\/A:1026549431380","article-title":"Light chain of botulinum A neurotoxin expressed as an inclusion body from a synthetic gene is catalytically and functionally active","volume":"19","author":"Ahmed","year":"2000","journal-title":"J. Protein Chem."},{"key":"10.1016\/j.jmb.2006.09.084_bib48","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0041-0101(03)00042-4","article-title":"Expression, purification, and efficacy of the type A botulinum neurotoxin catalytic domain fused to two translocation domain variants","volume":"41","author":"Jensen","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.jmb.2006.09.084_bib49","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/yea.320070307","article-title":"Applications of high efficiency lithium acetate transformation of intact yeast cells using single-stranded nucleic acids as carrier","volume":"7","author":"Gietz","year":"1991","journal-title":"Yeast"},{"key":"10.1016\/j.jmb.2006.09.084_bib50","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nbt785","article-title":"Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library","volume":"21","author":"Feldhaus","year":"2003","journal-title":"Nature Biotechnol."}],"container-title":["Journal of Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283606013088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283606013088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T16:05:36Z","timestamp":1627833936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022283606013088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0022283606013088"],"URL":"https:\/\/doi.org\/10.1016\/j.jmb.2006.09.084","relation":{},"ISSN":["0022-2836"],"issn-type":[{"value":"0022-2836","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}